19 Patents
- US123184072025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122905302025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122854432025Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122747162025Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122572692025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122460392025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122275562025Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US122028782025Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121955162025Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120844862024Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US119577162024Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119524092024Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers Preliminary Class
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US118914272024Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117796052023Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US117320212023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116552802023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116552812023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116033972023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites